Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OncoDNA logo — Genomic and theranostic company specializing in precision me...

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases

Founded 2014 Belgium Belgium 52 employees Series C Total: $35.38M Biotechnology, Health Care

General Information

Company Name OncoDNA
Founded Year 2014
Location Belgium Belgium +1
Employees 52
Industries Biotechnology, Health Care
Funding Stage Series C
Social

Get notified when OncoDNA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Sep 03, 2026

OncoDNA announced a major customer win with MVZ Pathologie Trier, which implemented the OncoDEEP® Kit for comprehensive genomic profiling of solid tumours.

Get alerts when OncoDNA shows new signals

About OncoDNA

OncoDNA, founded in 2012 in Belgium, is a prominent player in the Biotechnology and Health Care industries. Specializing in precision medicine, this genomic and theranostic company focuses on enhancing cancer and genetic disease treatments. Their slogan, "Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases," encapsulates their core mission.

The company's growth trajectory is marked by strategic partnerships with leading oncology organizations and a global reach. With over 100 employees spanning multiple countries, OncoDNA integrates molecular science and clinical expertise to offer an extensive portfolio: NGS services, biomarker testing, data analysis software, and clinical decision support tools.

Their most recent financial milestone includes a $7.09M Series C investment as of 01 July 2023. OncoDNA continues to seek potential partners to further their impact in precision medicine, particularly in the oncology sector.

Taxonomy: genomics, precision medicine, theranostics, cancer treatment, genetic diseases, biomarker testing, NGS services, clinical decision support, digital healthcare, molecular diagnostics, oncology, DNA sequencing, bioinformatics, medical diagnostics

Services & Products

OncoDEEP Kit
OncoSELECT Kit
OncoXPLORE Kit
Clinical Testing
Precision Enrollment
Clinical Data Intelligence (OncoCDI)
Automated Library Preparation
OncoKDM Software

Target Customers

Oncology Professionals Laboratory Professionals Pharma Companies Healthcare Institutions Biopharma Companies Researchers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• - 01 Jul 2023
Series B •••••• 6
Investor Investor Investor Investor Investor Investor
01 Feb 2020
Series A •••••• 1
Investor
01 Sep 2016

Latest News

View All
Biotech consortium led by PDC*line Pharma raises €8.1M for cancer vaccine — Tech
Biotech consortium led by PDC*line Pharma raises €8.1M for cancer vaccine
Tech Jan 23, 2024

OncoDNA Alternatives & Competitors

View All Alternatives
OncoDNA vs
Adela, Inc.
Adela, Inc. United States

Advancing the field of epigenomics to transform how cancer is detected and monitored.

Unknown
70 employees
Biotechnology, Pharmaceutical
Compare OncoDNA vs Adela, Inc.
OncoDNA vs
Pathnostics - A Diagnostics Solutions Company
Pathnostics - A Diagnostics Solutions Company United States

We pioneer approaches for better patient care and empower physicians to champion patient health toda...

Private Equity
171 employees
Biotechnology, Health Care
Compare OncoDNA vs Pathnostics - A Diagnostics Solutions Company
OncoDNA vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Series Unknown
121 employees
Biotechnology, Health Care
Compare OncoDNA vs ACT Genomics
View all alternatives

FAQ About OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases
OncoDNA was founded in 2014.
OncoDNA is headquartered in Belgium.
OncoDNA operates in the following industries: Biotechnology, Health Care.
OncoDNA has approximately 52 employees.
OncoDNA has completed 3 funding rounds, raising a total of $35.38M. The latest funding stage is Series C.
OncoDNA offers: OncoDEEP Kit, OncoSELECT Kit, OncoXPLORE Kit, Clinical Testing, Precision Enrollment, Clinical Data Intelligence (OncoCDI), Automated Library Preparation, OncoKDM Software, Project Care.
Top alternatives and competitors to OncoDNA include Adela, Inc., Pathnostics - A Diagnostics Solutions Company, ACT Genomics, Imagia Canexia Health, Guardant Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoDNA and Adela, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OncoDNA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy